Do You Qualify for GLP-1? A Friendly Eligibility Guide

The most common reason people don't pursue GLP-1 medication isn't cost, side effects, or needle fear — it's the assumption that they don't qualify. A Health Management Academy survey found that 70% of Americans believe GLP-1 medications are only accessible to higher-income patients or those with "good insurance," and more than half think you need a severe medical condition to be eligible.

Neither is true. The eligibility bar is lower than most people realize, the pathway is more accessible than ever, and the gap between "eligible" and "actually prescribed" is one of the biggest missed opportunities in American healthcare right now.

The two paths to eligibility

The number that should change how you think about this

That's not a gap in eligibility. It's a gap in action. The medications exist. The evidence is overwhelming. The prices have dropped dramatically. But most eligible patients never start the conversation — often because they assume they won't qualify, can't afford it, or feel that their weight "isn't bad enough" to warrant medication.

Here's the clinical reality: obesity is a chronic disease, not a character flaw. It has FDA-approved treatments that produce 15-21% body weight loss in trials. Bariatric surgery rates have already dropped 41.8% as GLP-1 prescriptions have risen — the medical community is increasingly treating obesity with medication rather than surgery.

Who doesn't qualify

GLP-1 medications are not appropriate for everyone. You should not take GLP-1 medications if you have a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) — these are rare conditions but represent an absolute contraindication due to thyroid tumor risks observed in animal studies. GLP-1 medications are not recommended during pregnancy or breastfeeding. If you have a history of pancreatitis, your prescriber will need to carefully evaluate the risk-benefit balance, as GLP-1 medications can occasionally trigger pancreatic inflammation.

Beyond these specific contraindications, the eligibility criteria are intentionally broad because the target population — adults with obesity or overweight with comorbidities — is enormous.

What if you're "borderline"?

Many people fall right around the BMI 27 threshold and wonder if they're "heavy enough" to qualify. The answer depends on whether you have a qualifying comorbidity — and many people have one without realizing it. Pre-diabetes, mildly elevated blood pressure, or early-stage fatty liver disease all count. A simple metabolic panel and blood pressure check during your consultation can identify conditions you may not have been tracking.

Additionally, BMI is a screening criterion, not a medical determination. A qualified prescriber evaluates your full health picture, not just a single number. Factors like body composition, metabolic markers, weight trajectory, and family history all inform the clinical decision.

Ready to find out? Here's your next step

The fastest way to determine your eligibility is a telehealth consultation — typically a 10-15 minute health questionnaire reviewed by a licensed prescriber. No lab work required upfront. No appointment scheduling. Most platforms deliver a determination within 24 hours.

If you qualify, you could have medication in your hands within a week. If you don't qualify, you've lost nothing but 10 minutes. Either way, you'll know — and knowing beats wondering.